Salivary Cortisol and Hypercortisolism in Type 2 Diabetes | MicrobiomeTrials← Back to trialsNCT07156370
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-09-11Est. Completion: 2027-06-30
Enrollment target: 500 participants Locations- Shanghai Sixth People's Hospital, Shanghai, China
Other microbiome trials you might be interested in
Endocrine DisordersHypertensionPrimary AldosteronismCortisol ExcessObesity & OverweightHealthy Adult
The goal of this trial is to learn whether wearable devices and hormone sampling can measure how the body changes during…
Zurich, SwitzerlandEst. completion Aug 2031
Adrenal Gland Neoplasm
The adrenal glands, located atop the kidneys, normally produce several types of hormones. Tumors of these glands may or …
Bethesda, United States